ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS

ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS

Aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are sodium channel blockers; pharmaceutical compositions that include an effective amount of the aryl-link-aryl thiazolidine-dione and ary l- link-aryl oxazolidine-dione compounds and a pharmaceutically acceptable carri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KUO, HOWARD C. H, MEINKE, PETER T, AYER, MICHELLE B, TYAGARAJAN, SRIRAM, CHAKRAVARTY, PRASUN K, PARSONS, WILLIAM H
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KUO, HOWARD C. H
MEINKE, PETER T
AYER, MICHELLE B
TYAGARAJAN, SRIRAM
CHAKRAVARTY, PRASUN K
PARSONS, WILLIAM H
description Aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are sodium channel blockers; pharmaceutical compositions that include an effective amount of the aryl-link-aryl thiazolidine-dione and ary l- link-aryl oxazolidine-dione compounds and a pharmaceutically acceptable carrier; and a method of treatment of acute pain, chronic pain, visceral pai n, inflammatory pain, or neuropathic pain, as well as irritable bowel syndrome, Crohns disease, epilepsy, partial and generalized tonic seizures, multiple sclerosis, bipolar depression, and tachy-arrhythmias by the administration o f an effective amount of aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2483771A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2483771A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2483771A13</originalsourceid><addsrcrecordid>eNrjZIhzDIr00fXx9PPWBbEUgkOdgkM8Q0JDXF0UQjw8HaP8fTxdPP1cdV08_f1cFRz9XBT8IzBEgxWC_V08Q30VnD0c_fxcfRScfPydvV2DgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo5GJhbG5uaGjoTERSgDnUDKr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS</title><source>esp@cenet</source><creator>KUO, HOWARD C. H ; MEINKE, PETER T ; AYER, MICHELLE B ; TYAGARAJAN, SRIRAM ; CHAKRAVARTY, PRASUN K ; PARSONS, WILLIAM H</creator><creatorcontrib>KUO, HOWARD C. H ; MEINKE, PETER T ; AYER, MICHELLE B ; TYAGARAJAN, SRIRAM ; CHAKRAVARTY, PRASUN K ; PARSONS, WILLIAM H</creatorcontrib><description>Aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are sodium channel blockers; pharmaceutical compositions that include an effective amount of the aryl-link-aryl thiazolidine-dione and ary l- link-aryl oxazolidine-dione compounds and a pharmaceutically acceptable carrier; and a method of treatment of acute pain, chronic pain, visceral pai n, inflammatory pain, or neuropathic pain, as well as irritable bowel syndrome, Crohns disease, epilepsy, partial and generalized tonic seizures, multiple sclerosis, bipolar depression, and tachy-arrhythmias by the administration o f an effective amount of aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are described.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040325&amp;DB=EPODOC&amp;CC=CA&amp;NR=2483771A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040325&amp;DB=EPODOC&amp;CC=CA&amp;NR=2483771A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KUO, HOWARD C. H</creatorcontrib><creatorcontrib>MEINKE, PETER T</creatorcontrib><creatorcontrib>AYER, MICHELLE B</creatorcontrib><creatorcontrib>TYAGARAJAN, SRIRAM</creatorcontrib><creatorcontrib>CHAKRAVARTY, PRASUN K</creatorcontrib><creatorcontrib>PARSONS, WILLIAM H</creatorcontrib><title>ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS</title><description>Aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are sodium channel blockers; pharmaceutical compositions that include an effective amount of the aryl-link-aryl thiazolidine-dione and ary l- link-aryl oxazolidine-dione compounds and a pharmaceutically acceptable carrier; and a method of treatment of acute pain, chronic pain, visceral pai n, inflammatory pain, or neuropathic pain, as well as irritable bowel syndrome, Crohns disease, epilepsy, partial and generalized tonic seizures, multiple sclerosis, bipolar depression, and tachy-arrhythmias by the administration o f an effective amount of aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIhzDIr00fXx9PPWBbEUgkOdgkM8Q0JDXF0UQjw8HaP8fTxdPP1cdV08_f1cFRz9XBT8IzBEgxWC_V08Q30VnD0c_fxcfRScfPydvV2DgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo5GJhbG5uaGjoTERSgDnUDKr</recordid><startdate>20040325</startdate><enddate>20040325</enddate><creator>KUO, HOWARD C. H</creator><creator>MEINKE, PETER T</creator><creator>AYER, MICHELLE B</creator><creator>TYAGARAJAN, SRIRAM</creator><creator>CHAKRAVARTY, PRASUN K</creator><creator>PARSONS, WILLIAM H</creator><scope>EVB</scope></search><sort><creationdate>20040325</creationdate><title>ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS</title><author>KUO, HOWARD C. H ; MEINKE, PETER T ; AYER, MICHELLE B ; TYAGARAJAN, SRIRAM ; CHAKRAVARTY, PRASUN K ; PARSONS, WILLIAM H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2483771A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KUO, HOWARD C. H</creatorcontrib><creatorcontrib>MEINKE, PETER T</creatorcontrib><creatorcontrib>AYER, MICHELLE B</creatorcontrib><creatorcontrib>TYAGARAJAN, SRIRAM</creatorcontrib><creatorcontrib>CHAKRAVARTY, PRASUN K</creatorcontrib><creatorcontrib>PARSONS, WILLIAM H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KUO, HOWARD C. H</au><au>MEINKE, PETER T</au><au>AYER, MICHELLE B</au><au>TYAGARAJAN, SRIRAM</au><au>CHAKRAVARTY, PRASUN K</au><au>PARSONS, WILLIAM H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS</title><date>2004-03-25</date><risdate>2004</risdate><abstract>Aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are sodium channel blockers; pharmaceutical compositions that include an effective amount of the aryl-link-aryl thiazolidine-dione and ary l- link-aryl oxazolidine-dione compounds and a pharmaceutically acceptable carrier; and a method of treatment of acute pain, chronic pain, visceral pai n, inflammatory pain, or neuropathic pain, as well as irritable bowel syndrome, Crohns disease, epilepsy, partial and generalized tonic seizures, multiple sclerosis, bipolar depression, and tachy-arrhythmias by the administration o f an effective amount of aryl-link-aryl thiazolidine-dione and aryl-link-aryl oxazolidine-dione compounds are described.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2483771A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title ARYL-LINK-ARYL SUBSTITUTED THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE AS SODIUM CHANNEL BLOCKERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A30%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KUO,%20HOWARD%20C.%20H&rft.date=2004-03-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2483771A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true